Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW842166 in Patients With Osteoarthritis
NCT00479427Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GW842166 in osteoarthritis (OA) (2 arms), sponsored by GSK. Primary endpoint: Western Ontario and McMasters University Osteoarthritis Index Pain Subscore at 14 days. Started Jul 2007; status: completed.
02
Drugs
GW842166
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00479427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479427.